Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal SyndromeManagement of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapyUpdates on the management of diabetes in dialysis patientsLatest consensus and update on protein-energy wasting in chronic kidney diseaseReverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric PopulationA Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney InjuryThyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patientsHemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.Obesity and Kidney Disease: Hidden Consequences of the Epidemic.Updates in hyperkalemia: Outcomes and therapeutic strategies.Pragmatic Clinical Trials in CKD: Opportunities and ChallengesRacial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events.Age, Race and Cardiovascular Outcomes in African American VeteransResponse to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans.Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans.The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease.Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients.Association of body mass index with outcomes in patients with CKD.Effect of age and dialysis vintage on obesity paradox in long-term hemodialysis patients.Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease.Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis.Correlates of low hemoglobin A1c in maintenance hemodialysis patients.Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysisBlood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.Accuracy and limitations of the diagnosis of malnutrition in dialysis patientsRacial differences in estimated GFR decline, ESRD, and mortality in an integrated health systemSurvival advantage in black versus white men with CKD: effect of estimated GFR and case mix.Outcomes associated with microalbuminuria: effect modification by chronic kidney diseaseDeveloping an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients.Donor race and outcomes in kidney transplant recipientsAssociation of depression and antidepressant use with mortality in a large cohort of patients with nondialysis-dependent CKD.Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomesManagement of mineral and bone disorder after kidney transplantation.Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients.Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney diseaseAge and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes.Charlson comorbidity score is a strong predictor of mortality in hemodialysis patientsGlycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study
P50
Q26753862-CCDBBC9F-2820-4F76-95AC-DFD95C8C048CQ26859689-ED5C1B40-8DFC-4188-BBC9-1247F176EB82Q27024782-3CF88424-1A24-44C3-984A-D5E802BB1985Q27027875-7EB46923-95A2-4C8C-AE78-BB3E59012F62Q28081914-BB8FA906-D795-4312-A381-E8314FA4DF47Q28084271-6BEDAFAB-CC4B-44A8-8E36-1A93FEB9482EQ28647790-D139848B-EA34-4FEA-8231-9FDAE4FE0F68Q30235345-1F04F3DB-21D8-4EA7-990E-76DD24CC22FFQ30235506-D3A8A8FD-D0BA-4752-B051-C904DF455EF8Q30245585-78331C8D-C234-4DD2-907F-9BEDB3877720Q30249723-ECE8FDEE-6812-4045-ADCB-F8A908FC65EBQ30275940-AD08B78A-6C54-42EF-9649-0EA3E88624B3Q30276315-02700CEB-6437-44F3-91C6-BBAEF97FC1C8Q30277111-BC353379-8F5F-48AA-AF01-BD3171ADA5B7Q30278663-EF49CCDB-0A67-478A-9CD7-CE7A23FDFDC3Q30279244-02F97F0F-1B22-4789-82A8-2DCB0FE2FA28Q30361177-D9B0B31C-812D-4A54-9FFF-0566F45EA467Q30370842-2E41A541-106F-4674-A2A0-4C68317FFDD6Q30371128-B299B326-BBA3-4CAD-91B9-5DFC8344D22AQ30405987-0279BEB5-6C5B-4D3C-8EC5-1D9EF411B556Q30407790-CB717E58-DE79-4593-88F1-24E462C3D7FBQ30407860-05213825-FD10-492F-BFB8-C63AC838283AQ30407931-8DCBFADA-268B-4286-8D23-BA706305353CQ30408117-242E6D13-00FD-4238-830B-3DC6D16DE1ABQ30408489-C8F0043F-B609-47DB-B6D6-C18C093B3191Q30410815-A748AE53-ADEF-45F4-A688-FD1E01FA3701Q30410840-A826298F-8F88-4F93-BB2A-0DB06F6376D3Q30411449-3F8BF9DF-4523-4984-9159-521E2D71875AQ30411453-A4904E34-E158-423D-977F-63EF4338C4E0Q30413815-77973C65-78FD-4A14-9BFB-E744CE0EC362Q30413995-14D89A12-A021-4B25-9EAE-D7E348F99988Q30415457-161D41DD-1214-47BA-BC14-72EB8FAF8B7DQ30416394-6DDAD043-7217-451E-AA43-5348BF50C36CQ30417992-C3A75117-B837-4B73-B224-129FE410982CQ30418461-6568722F-1526-4650-BF9D-BA04A12193EBQ30418567-676D6864-6EC2-4D0E-9F7D-D989A337BE90Q30418571-880DA29B-4862-4F02-9F2D-E70DB012DB1FQ30418972-0FF11906-1314-4A94-88A8-BAE83C8EBF77Q30421952-8B74CDC4-0711-4EE2-8C2A-FB726A705D28Q30422123-4FCB9D5A-0CDE-4B54-8195-9B5454093098
P50
description
American nephrologist and epidemiologist
@en
name
Csaba P. Kovesdy
@ast
Csaba P. Kovesdy
@en
Csaba P. Kovesdy
@es
Csaba P. Kovesdy
@nl
type
label
Csaba P. Kovesdy
@ast
Csaba P. Kovesdy
@en
Csaba P. Kovesdy
@es
Csaba P. Kovesdy
@nl
prefLabel
Csaba P. Kovesdy
@ast
Csaba P. Kovesdy
@en
Csaba P. Kovesdy
@es
Csaba P. Kovesdy
@nl